ProShares Ultra Nasdaq Biotechnology · $102M$14,578
BIBBIB vsVOOVOOVanguard S&P 500 ETF · $1.00T$18,115
$10,000 five years ago, dividends reinvested · they hold 1.2% in common
BIBMeasureVOO
Returns · dividends reinvested
+56.9%Year to dateJan 1 → Nov 4+13.4%
+80.1%1 yearTotal return+13.5%
+46.2%3 years · per year$10,000 became $31,270 · $19,172+24.2%
+7.8%5 years · per year$10,000 became $14,578 · $18,115+12.6%
Cost and income
1.17%Expense ratio$117 · $3 a year on $10k · lower is better0.03%
0.18%Trailing 12-mo yield$18 · $105 a year on $10k1.05%
Risk · past year
−17.9%Worst dropSmaller is better−8.9%
44.9%VolatilityLower is calmer12.8%
BIBVOO Winner of the row, in its colourEach row: the bigger of the two fills its side
3–5VOO wins
End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns